Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Fundamental Analysis

NASDAQ:JBSS - Nasdaq - US8004221078 - Common Stock - Currency: USD

63.24  -0.18 (-0.28%)

After market: 63.24 0 (0%)

Fundamental Rating

5

Overall JBSS gets a fundamental rating of 5 out of 10. We evaluated JBSS against 91 industry peers in the Food Products industry. While JBSS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. JBSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

JBSS had positive earnings in the past year.
In the past year JBSS had a positive cash flow from operations.
JBSS had positive earnings in each of the past 5 years.
JBSS had a positive operating cash flow in each of the past 5 years.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

JBSS's Return On Assets of 9.39% is amongst the best of the industry. JBSS outperforms 90.11% of its industry peers.
With an excellent Return On Equity value of 15.99%, JBSS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
JBSS has a better Return On Invested Capital (11.65%) than 87.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBSS is significantly below the industry average of 28.39%.
The last Return On Invested Capital (11.65%) for JBSS is well below the 3 year average (17.40%), which needs to be investigated, but indicates that JBSS had better years and this may not be a problem.
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROIC 11.66%
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 5.00%, JBSS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Profit Margin of JBSS has grown nicely.
With a decent Operating Margin value of 7.15%, JBSS is doing good in the industry, outperforming 68.13% of the companies in the same industry.
In the last couple of years the Operating Margin of JBSS has grown nicely.
JBSS's Gross Margin of 18.48% is in line compared to the rest of the industry. JBSS outperforms 47.25% of its industry peers.
JBSS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.15%
PM (TTM) 5%
GM 18.48%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

JBSS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
JBSS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JBSS has been increased compared to 5 years ago.
The debt/assets ratio for JBSS is higher compared to a year ago.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.00 indicates that JBSS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.00, JBSS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
JBSS has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
JBSS has a better Debt to Equity ratio (0.28) than 67.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 5
ROIC/WACC1.14
WACC10.2%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

JBSS has a Current Ratio of 2.01. This indicates that JBSS is financially healthy and has no problem in meeting its short term obligations.
JBSS has a Current ratio of 2.01. This is in the better half of the industry: JBSS outperforms 65.93% of its industry peers.
JBSS has a Quick Ratio of 2.01. This is a bad value and indicates that JBSS is not financially healthy enough and could expect problems in meeting its short term obligations.
JBSS's Quick ratio of 0.53 is on the low side compared to the rest of the industry. JBSS is outperformed by 70.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.53
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. Growth

3.1 Past

The earnings per share for JBSS have decreased strongly by -14.75% in the last year.
Measured over the past years, JBSS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.51% on average per year.
Looking at the last year, JBSS shows a small growth in Revenue. The Revenue has grown by 7.40% in the last year.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.34 indicates a correct valuation of JBSS.
Based on the Price/Earnings ratio, JBSS is valued a bit cheaper than 70.33% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.15, JBSS is valued rather cheaply.
Industry RankSector Rank
PE 13.34
Fwd PE N/A
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBSS indicates a somewhat cheap valuation: JBSS is cheaper than 78.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.09
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The excellent profitability rating of JBSS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.57
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

JBSS has a Yearly Dividend Yield of 1.35%. Purely for dividend investing, there may be better candidates out there.
JBSS's Dividend Yield is comparable with the industry average which is at 4.75.
Compared to an average S&P500 Dividend Yield of 2.42, JBSS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

The dividend of JBSS has a limited annual growth rate of 3.19%.
JBSS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.19%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

JBSS pays out 65.00% of its income as dividend. This is not a sustainable payout ratio.
JBSS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (6/30/2025, 8:00:02 PM)

After market: 63.24 0 (0%)

63.24

-0.18 (-0.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-18 2025-08-18
Inst Owners92.71%
Inst Owner Change-3.31%
Ins Owners0.96%
Ins Owner Change-7.47%
Market Cap743.70M
Analysts85.71
Price TargetN/A
Short Float %2.22%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly Dividend3
Dividend Growth(5Y)3.19%
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.34
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF 25.43
P/B 2.15
P/tB 2.25
EV/EBITDA 7.09
EPS(TTM)4.74
EY7.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)2.49
OCFY3.93%
SpS94.2
BVpS29.47
TBVpS28.07
PEG (NY)N/A
PEG (5Y)1.57
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROCE 19.05%
ROIC 11.66%
ROICexc 11.68%
ROICexgc 12.08%
OM 7.15%
PM (TTM) 5%
GM 18.48%
FCFM N/A
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
ROICexc(3y)17.45%
ROICexc(5y)18.22%
ROICexgc(3y)18.35%
ROICexgc(5y)19.31%
ROCE(3y)24.69%
ROCE(5y)25.84%
ROICexcg growth 3Y-10.65%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y-9.97%
ROICexc growth 5Y1.18%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
F-Score3
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA 0.91
Cap/Depr 181.92%
Cap/Sales 4.34%
Interest Coverage 250
Cash Conversion 27.68%
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 0.53
Altman-Z 5
F-Score3
WACC10.2%
ROIC/WACC1.14
Cap/Depr(3y)104.47%
Cap/Depr(5y)106.99%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.25%
Profit Quality(3y)96.67%
Profit Quality(5y)102.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.8%
EBIT growth 3Y-0.88%
EBIT growth 5Y7.24%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.41%
FCF growth 3Y-2.64%
FCF growth 5Y1.41%
OCF growth 1Y-72.04%
OCF growth 3Y-0.97%
OCF growth 5Y4.02%